Curve Biosciences: Nathan Hunkapiller, Chuba Oyolu

Curve Biosciences, a company leveraging its Chronic Disease Tissue Atlas to develop liquid biopsy tests and other products for chronic disease care, this week announced the appointment of Nathan Hunkapiller as CSO and Chuba Oyolu as chief technology officer.

Hunkapiller joined the company last year as a scientific adviser. Prior to that he was senior VP of R&D at Grail. Earlier, he was VP of R&D at Natera. He holds a PhD in biomedical sciences from the University of California, San Francisco and a bachelor's degree in biology from Stanford University.

Oyolu joined Curve last year in a technical advisory role. He was previously founding scientist and senior site director at Counsyl. He holds a PhD in bioengineering from Stanford University and a bachelor's degree in electrical engineering from the University of Pittsburgh.